Nuvation Bio (Panacea Acquisition) ^{Priced, NYSE: NUVB}

We are a newly organized blank check company. While we may pursue an initial business combination opportunity in any industry or geographical location, we intend to capitalize on our management team’s background and experience to identify promising opportunities in the biotechnology sector. Our sponsor is an affiliate of EcoR1 Capital, LLC (“EcoR1”), an investment firm with over $1.8 billion in regulatory assets under management as of January 1, 2020. EcoR1 was established in March 2013 by Oleg Nodelman and is focused on therapeutic companies within the biotechnology sector. We believe the experience of our team, strengthened by their industry network and our experienced board of directors, will enhance our management team’s ability to source viable prospective target businesses, capitalize them and ensure public-market readiness. We believe that our management team is equipped with the knowledge, experience, capital and human resources to pursue unique opportunities that will offer attractive risk-adjusted returns. Oleg Nodelman has been our Chief Executive officer since our inception in April 2020 and is our Chairman Nominee. Scott Perlen has been our Chief Financial Officer since our inception in April 2020. Mr. Perlen has been the Chief Financial Officer of EcoR1 since joining the firm in 2019.